● Recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Condition: Ocular Myasthenia Gravis · Sponsor: UCB Biopharma SRL

PhasePhase 3

Planned participants120

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of the study is to demonstrate the efficacy, safety and tolerability of rozanolixizumab compared with placebo in the treatment of adult study participants with Ocular Myasthenia Gravis.

This description comes directly from the study's public registry record.

Talk to the study team

UCB Cares · +18445992273 · ucbcares@ucb.com

UCB Cares · 00184459922733 (UCB) · ucbcares@ucb.com

Always discuss trial participation with your own doctor first.

Locations (2)

Mg0038 10106	Amherst, New York, United States	Recruiting
Mg0038 10103	Columbus, Ohio, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07463521